Pulmonary Section, Department of Medicine, VA Medical Center, Minneapolis, Minnesota 55417, USA.
Am J Respir Crit Care Med. 2010 Oct 1;182(7):890-6. doi: 10.1164/rccm.200910-1579OC. Epub 2010 Jan 14.
The effect of disease management for chronic obstructive pulmonary disease (COPD) is not well established.
To determine whether a simplified disease management program reduces hospital admissions and emergency department (ED) visits due to COPD.
We performed a randomized, adjudicator-blinded, controlled, 1-year trial at five Veterans Affairs medical centers of 743 patients with severe COPD and one or more of the following during the previous year: hospital admission or ED visit for COPD, chronic home oxygen use, or course of systemic corticosteroids for COPD. Control group patients received usual care. Intervention group patients received a single 1- to 1.5-hour education session, an action plan for self-treatment of exacerbations, and monthly follow-up calls from a case manager.
We determined the combined number of COPD-related hospitalizations and ED visits per patient. Secondary outcomes included hospitalizations and ED visits for all causes, respiratory medication use, mortality, and change in Saint George's Respiratory Questionnaire. After 1 year, the mean cumulative frequency of COPD-related hospitalizations and ED visits was 0.82 per patient in usual care and 0.48 per patient in disease management (difference, 0.34; 95% confidence interval, 0.15-0.52; P < 0.001). Disease management reduced hospitalizations for cardiac or pulmonary conditions other than COPD by 49%, hospitalizations for all causes by 28%, and ED visits for all causes by 27% (P < 0.05 for all).
A relatively simple disease management program reduced hospitalizations and ED visits for COPD. Clinical trial registered with www.clinicaltrials.gov (NCT00126776).
慢性阻塞性肺疾病(COPD)的疾病管理效果尚未明确。
确定简化的疾病管理方案是否可减少 COPD 所致的住院和急诊就诊次数。
我们在五家退伍军人事务医疗中心开展了一项为期 1 年、随机、评判者设盲、对照临床试验,共纳入 743 例患有严重 COPD 且在过去 1 年内存在以下至少 1 项情况的患者:因 COPD 住院或急诊就诊、慢性家庭氧疗、或因 COPD 接受全身性皮质类固醇治疗。对照组患者接受常规治疗,干预组患者除常规治疗外,还接受 1 至 1.5 小时的教育课程、一份自我治疗加重期的行动计划以及每月 1 次由个案管理员进行的随访电话。
我们确定了每位患者 COPD 相关住院和急诊就诊的总和次数。次要结局包括所有原因所致的住院和急诊就诊、呼吸药物使用、死亡率以及圣乔治呼吸问卷的变化。1 年后,常规治疗组患者 COPD 相关住院和急诊就诊的平均累积频率为 0.82 次/人,疾病管理组为 0.48 次/人(差异为 0.34;95%置信区间,0.15-0.52;P<0.001)。疾病管理使 COPD 以外的心脏或肺部疾病的住院率降低了 49%,所有原因的住院率降低了 28%,所有原因的急诊就诊率降低了 27%(所有 P 值均<0.05)。
相对简单的疾病管理方案可减少 COPD 的住院和急诊就诊次数。临床试验注册于 www.clinicaltrials.gov(NCT00126776)。